246 related articles for article (PubMed ID: 29587298)
1. The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III.
Xu W; Song F; Wang B; Li K; Tian M; Yu M; Pan X; Shi B; Liu J; Gu J; Li Z; Jiang H
Cell Physiol Biochem; 2018; 46(1):226-237. PubMed ID: 29587298
[TBL] [Abstract][Full Text] [Related]
2. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
[TBL] [Abstract][Full Text] [Related]
3. Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III.
Jiang H; Wang H; Tan Z; Hu S; Wang H; Shi B; Yang L; Li P; Gu J; Wang H; Li Z
J Biol Chem; 2011 Feb; 286(7):5913-20. PubMed ID: 21163950
[TBL] [Abstract][Full Text] [Related]
4. The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Yang Y; Jiang H; Gao H; Kong J; Zhang P; Hu S; Shi B; Zhang P; Yao M; Li Z
Neoplasia; 2012 Jun; 14(6):509-18. PubMed ID: 22787432
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y
Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892
[TBL] [Abstract][Full Text] [Related]
7. PAQR3 suppresses the growth of non-small cell lung cancer cells via modulation of EGFR-mediated autophagy.
Cao Q; You X; Xu L; Wang L; Chen Y
Autophagy; 2020 Jul; 16(7):1236-1247. PubMed ID: 31448672
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12.
Xu W; Bi Y; Zhang J; Kong J; Jiang H; Tian M; Li K; Wang B; Chen C; Song F; Pan X; Shi B; Kong X; Gu J; Cai X; Li Z
Oncotarget; 2015 Nov; 6(36):38840-53. PubMed ID: 26474285
[TBL] [Abstract][Full Text] [Related]
9. Intracellular alpha-fetoprotein interferes with all-trans retinoic acid induced ATG7 expression and autophagy in hepatocellular carcinoma cells.
Wang S; Feng R; Shi Y; Chen D; Weng H; Ding H; Zhang C
Sci Rep; 2021 Jan; 11(1):2146. PubMed ID: 33495541
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency.
Li N; Chu Y; Yao L; Ying X; Jiang H; Zhou M; Xu C
J Cancer Res Clin Oncol; 2011 Oct; 137(10):1455-61. PubMed ID: 21809030
[TBL] [Abstract][Full Text] [Related]
11. Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma.
Chen YJ; Chi CW; Su WC; Huang HL
Oncotarget; 2014 Jul; 5(13):4845-54. PubMed ID: 24947784
[TBL] [Abstract][Full Text] [Related]
12. EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression.
Luo X; Xie H; Long X; Zhou M; Xu Z; Shi B; Jiang H; Li Z
PLoS One; 2013; 8(12):e83332. PubMed ID: 24376686
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside II sensitizes human hepatocellular carcinoma cells to 5-fluorouracil via suppression of autophagy.
Wang M; Huang C; Su Y; Yang C; Xia Q; Xu DJ
J Pharm Pharmacol; 2017 Jun; 69(6):743-752. PubMed ID: 28266023
[TBL] [Abstract][Full Text] [Related]
14. Artesunate Attenuates Pro-Inflammatory Cytokine Release from Macrophages by Inhibiting TLR4-Mediated Autophagic Activation via the TRAF6-Beclin1-PI3KC3 Pathway.
Kuang M; Cen Y; Qin R; Shang S; Zhai Z; Liu C; Pan X; Zhou H
Cell Physiol Biochem; 2018; 47(2):475-488. PubMed ID: 29794440
[TBL] [Abstract][Full Text] [Related]
15. Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN-glioblastoma in vivo.
Xu W; Bi Y; Kong J; Zhang J; Wang B; Li K; Tian M; Pan X; Shi B; Gu J; Jiang H; Kong X; Li Z
Oncotarget; 2016 Apr; 7(17):24752-65. PubMed ID: 27029073
[TBL] [Abstract][Full Text] [Related]
16. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.
Li YY; Lam SK; Mak JC; Zheng CY; Ho JC
Lung Cancer; 2013 Sep; 81(3):354-361. PubMed ID: 23769318
[TBL] [Abstract][Full Text] [Related]
17. Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy.
Wu JY; Wang ZX; Zhang G; Lu X; Qiang GH; Hu W; Ji AL; Wu JH; Jiang CP
Int J Nanomedicine; 2018; 13():1265-1280. PubMed ID: 29551896
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
[TBL] [Abstract][Full Text] [Related]
19. MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma.
Ou Y; He J; Liu Y
IUBMB Life; 2018 Jun; 70(6):468-478. PubMed ID: 29676845
[TBL] [Abstract][Full Text] [Related]
20. Radiation induces autophagic cell death via the p53/DRAM signaling pathway in breast cancer cells.
Cui L; Song Z; Liang B; Jia L; Ma S; Liu X
Oncol Rep; 2016 Jun; 35(6):3639-47. PubMed ID: 27109777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
